Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolus (EOLS) Shares Issued (2018 - 2025)

Evolus (EOLS) has disclosed Shares Issued for 7 consecutive years, with -$1.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Issued rose 97.66% year-over-year to -$1.1 million, compared with a TTM value of -$45.2 million through Sep 2025, down 188.29%, and an annual FY2024 reading of $4.9 million, up 2013.42% over the prior year.
  • Shares Issued was -$1.1 million for Q4 2025 at Evolus, down from $18000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $47.0 million in Q1 2024 and bottomed at -$46.3 million in Q4 2024.
  • Average Shares Issued over 5 years is $350388.9, with a median of $48000.0 recorded in 2023.
  • Peak annual rise in Shares Issued hit 180684.62% in 2024, while the deepest fall reached 128791.67% in 2024.
  • Year by year, Shares Issued stood at $1000.0 in 2021, then soared by 35400.0% to $355000.0 in 2022, then plummeted by 89.86% to $36000.0 in 2023, then tumbled by 128791.67% to -$46.3 million in 2024, then skyrocketed by 97.66% to -$1.1 million in 2025.
  • Business Quant data shows Shares Issued for EOLS at -$1.1 million in Q4 2025, $18000.0 in Q3 2025, and $323000.0 in Q2 2025.